Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 3098542, 9 pages
https://doi.org/10.1155/2017/3098542
Research Article

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients

1Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
2Department of Gynecologic Oncology, Institute for Cancer Genetics and Informatics and University of Oslo, Oslo, Norway
3MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
4DOCs International, Buckinghamshire, UK
5Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona, Spain
6Department of Medical Sciences, Medical School, University of Girona, Girona, Spain
7Medical Oncology, Royal Prince Alfred Hospital and Concord Repatriation General Hospital and Chris O’Brien Lifehouse, Sydney, NSW, Australia
8Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

Correspondence should be addressed to Åslaug Helland; on.oiu.nisidem@dnalleha

Received 14 November 2016; Accepted 11 January 2017; Published 15 February 2017

Academic Editor: Ines Zidi

Copyright © 2017 Ann Rita Halvorsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ann Rita Halvorsen, Gunnar Kristensen, Andy Embleton, et al., “Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients,” Disease Markers, vol. 2017, Article ID 3098542, 9 pages, 2017. https://doi.org/10.1155/2017/3098542.